Green Lifescience Statistics

Total Valuation

Green Lifescience has a market cap or net worth of KRW 35.08 billion. The enterprise value is 26.53 billion.

Market Cap	35.08B
Enterprise Value	26.53B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Green Lifescience has 20.00 million shares outstanding. The number of shares has decreased by -18.59% in one year.

Current Share Class	n/a
Shares Outstanding	20.00M
Shares Change (YoY)	-18.59%
Shares Change (QoQ)	+1.08%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.58
PB Ratio	0.94
P/TBV Ratio	0.99
P/FCF Ratio	16.14
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 170.95, with an EV/FCF ratio of 12.21.

EV / Earnings	-2.09
EV / Sales	1.23
EV / EBITDA	170.95
EV / EBIT	n/a
EV / FCF	12.21

Financial Position

The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.14.

Current Ratio	2.96
Quick Ratio	2.26
Debt / Equity	0.14
Debt / EBITDA	32.23
Debt / FCF	2.30
Interest Coverage	-4.93

Financial Efficiency

Return on equity (ROE) is -29.56% and return on invested capital (ROIC) is -1.33%.

Return on Equity (ROE)	-29.56%
Return on Assets (ROA)	-1.26%
Return on Capital (ROIC)	-1.33%
Revenue Per Employee	308.38M
Profits Per Employee	-180.91M
Employee Count	70
Asset Turnover	0.42
Inventory Turnover	4.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.37% in the last 52 weeks. The beta is 1.15, so Green Lifescience's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-20.37%
50-Day Moving Average	1,745.22
200-Day Moving Average	2,073.74
Relative Strength Index (RSI)	44.11
Average Volume (20 Days)	83,949

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Green Lifescience had revenue of KRW 21.59 billion and -12.66 billion in losses. Loss per share was -652.95.

Revenue	21.59B
Gross Profit	1.47B
Operating Income	-1.03B
Pretax Income	-12.66B
Net Income	-12.66B
EBITDA	155.19M
EBIT	-1.03B
Loss Per Share	-652.95

Full Income Statement

Balance Sheet

The company has 13.55 billion in cash and 5.00 billion in debt, giving a net cash position of 8.55 billion or 427.46 per share.

Cash & Cash Equivalents	13.55B
Total Debt	5.00B
Net Cash	8.55B
Net Cash Per Share	427.46
Equity (Book Value)	35.61B
Book Value Per Share	1,865.38
Working Capital	13.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.14 billion and capital expenditures -969.63 million, giving a free cash flow of 2.17 billion.

Operating Cash Flow	3.14B
Capital Expenditures	-969.63M
Free Cash Flow	2.17B
FCF Per Share	108.66

Full Cash Flow Statement

Margins

Gross margin is 6.82%, with operating and profit margins of -4.77% and -58.66%.

Gross Margin	6.82%
Operating Margin	-4.77%
Pretax Margin	-58.66%
Profit Margin	-58.66%
EBITDA Margin	0.72%
EBIT Margin	-4.77%
FCF Margin	10.07%

Dividends & Yields

Green Lifescience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	18.59%
Shareholder Yield	18.59%
Earnings Yield	-37.23%
FCF Yield	6.20%

Stock Splits

The last stock split was on September 5, 2023. It was a forward split with a ratio of 1.3333333333.

Last Split Date	Sep 5, 2023
Split Type	Forward
Split Ratio	1.3333333333

Scores

Green Lifescience has an Altman Z-Score of 4.71.

Altman Z-Score	4.71
Piotroski F-Score	n/a